Endoscopic ultrasound, a common test for adults, is rarely used on children. Researchers in Israel who studied the efficacy of the test on these smaller patients have found it to be a safe and effective tool for diagnosing pediatric gastroenterology patients.
Endoscopic ultrasound, a common test for adults, is rarely used on children. Researchers in Israel who studied the efficacy of the test on these smaller patients have found it to be a safe and effective tool for diagnosing pediatric gastroenterology patients.
Dr. Shlomi Cohen and colleagues in the Pediatric Gastroenterology Unit at Dana's Children's Hospital in Tel Aviv used endoscopic ultrasound to examine 21 boys and 11 girls at their facility over six years. The patients ranged from 1.5 years old to 18 years old, with a mean age of 12.
For 19 children, the test was conducted to examine the biliary tract and pancreas. Nine of the 19 showed evidence of recurrent pancreatitis, six had a mass or cyst, and four had obstructive jaundice.
Endoscopic ultrasound was used to examine the esophagus in eight children. Four of these had a stenosis, while two had an esophageal mass, and two had suspected duplication cysts.
The other five patients underwent two exams of the stomach, two of the rectum, and one of the duodenum. In total, 18 children were examined while under conscious sedation, 12 were under unconscious sedation, and two had no anesthesia. The researchers also performed endoscopic ultrasound-guided fine-needle aspiration during the exam in seven cases.
None of the 32 exams had complications, and all were considered successful. The endoscopic ultrasound results changed the diagnosis or therapy in 14 cases.
The researchers concluded that endoscopic ultrasound is a safe, effective way to examine pediatric patients, especially those with pancreatobiliary or esophageal disorders. They note that it had a significant impact in nearly half the patients in their practice and consider it a very useful test.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.
FDA Clears Point-Of-Care Ultrasound Platform and AI Software for Neuraxial Procedures
July 17th 2025The dual FDA clearances for the Accuro 3S point-of-care ultrasound device and the SpineNav-AI machine learning-based software may enhance precision and safety with ultrasound-guided neuraxial procedures.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.